Actavia Life Sciences PEG Ratio

Actavia Life Sciences (RASP) currently reports a PEG ratio of 0.07. That is below the Healthcare sector average of 27.75. Use the charts on this page to explore Actavia Life Sciences's PEG ratio history and peer comparisons.

Actavia Life Sciences's PEG ratio of 0.07 is lower than the Healthcare sector average of 27.75. That is roughly 99.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Actavia Life Sciences's market price to a fundamental measure such as earnings, sales, or book value. At 0.07, RASP can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 0.07, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for Actavia Life Sciences, and consider following RASP for alerts when major investors trade the stock.

Actavia Life Sciences is classified in the Healthcare sector. On PEG ratio, it currently shows 0.07 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RASP with unrelated industries.